Trial Profile
Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation: Monocentric Prospective Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2023
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary)
- Indications Paraganglioma; Phaeochromocytoma
- Focus Diagnostic use
- Acronyms DOTATATE
- 05 Apr 2023 Status changed from recruiting to completed.
- 24 Aug 2015 New trial record